Cargando…

Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome

A 32-year-old woman undergoing an in vitro fertilization program was admitted to our hospital with the diagnosis of severe ovarian hyperstimulation syndrome (OHSS). Transvaginal ultrasonography showed two gestational sacs. Treatment with fluid restriction, serum albumin and intravenous furosemide wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez, Gemma Grau, Campanario, Oriol Giménez, Serra, Nuria Pons, Llobell, Mireia Cairó, Mena, Pedro Almagro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822664/
https://www.ncbi.nlm.nih.gov/pubmed/31742201
http://dx.doi.org/10.12890/2019_001253
_version_ 1783464379817132032
author Gómez, Gemma Grau
Campanario, Oriol Giménez
Serra, Nuria Pons
Llobell, Mireia Cairó
Mena, Pedro Almagro
author_facet Gómez, Gemma Grau
Campanario, Oriol Giménez
Serra, Nuria Pons
Llobell, Mireia Cairó
Mena, Pedro Almagro
author_sort Gómez, Gemma Grau
collection PubMed
description A 32-year-old woman undergoing an in vitro fertilization program was admitted to our hospital with the diagnosis of severe ovarian hyperstimulation syndrome (OHSS). Transvaginal ultrasonography showed two gestational sacs. Treatment with fluid restriction, serum albumin and intravenous furosemide was started, and repeated thoracentesis and paracenteses were performed. In the absence of clinical improvement, the patient was transferred to the intensive care unit and a therapeutic abortion was suggested. Due to the similarities between OHSS and idiopathic systemic capillary leak syndrome, we offered the patient compassionate treatment with intravenous immunoglobulins. After administration, the patient showed rapid improvement and we were able to suspend intravenous furosemide and serum albumin. She was discharged, and pregnancy has continued normally to date. LEARNING POINTS: OHSS is an infrequent yet serious complication of assisted reproductive treatment that involves increased capillary permeability. In severe refractory cases, immunoglobulins may be a useful and safe treatment to reverse this syndrome.
format Online
Article
Text
id pubmed-6822664
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SMC Media Srl
record_format MEDLINE/PubMed
spelling pubmed-68226642019-11-18 Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome Gómez, Gemma Grau Campanario, Oriol Giménez Serra, Nuria Pons Llobell, Mireia Cairó Mena, Pedro Almagro Eur J Case Rep Intern Med Articles A 32-year-old woman undergoing an in vitro fertilization program was admitted to our hospital with the diagnosis of severe ovarian hyperstimulation syndrome (OHSS). Transvaginal ultrasonography showed two gestational sacs. Treatment with fluid restriction, serum albumin and intravenous furosemide was started, and repeated thoracentesis and paracenteses were performed. In the absence of clinical improvement, the patient was transferred to the intensive care unit and a therapeutic abortion was suggested. Due to the similarities between OHSS and idiopathic systemic capillary leak syndrome, we offered the patient compassionate treatment with intravenous immunoglobulins. After administration, the patient showed rapid improvement and we were able to suspend intravenous furosemide and serum albumin. She was discharged, and pregnancy has continued normally to date. LEARNING POINTS: OHSS is an infrequent yet serious complication of assisted reproductive treatment that involves increased capillary permeability. In severe refractory cases, immunoglobulins may be a useful and safe treatment to reverse this syndrome. SMC Media Srl 2019-10-02 /pmc/articles/PMC6822664/ /pubmed/31742201 http://dx.doi.org/10.12890/2019_001253 Text en © EFIM 2019 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Articles
Gómez, Gemma Grau
Campanario, Oriol Giménez
Serra, Nuria Pons
Llobell, Mireia Cairó
Mena, Pedro Almagro
Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
title Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
title_full Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
title_fullStr Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
title_full_unstemmed Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
title_short Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
title_sort immunoglobulin treatment in severe ovarian hyperstimulation syndrome
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822664/
https://www.ncbi.nlm.nih.gov/pubmed/31742201
http://dx.doi.org/10.12890/2019_001253
work_keys_str_mv AT gomezgemmagrau immunoglobulintreatmentinsevereovarianhyperstimulationsyndrome
AT campanariooriolgimenez immunoglobulintreatmentinsevereovarianhyperstimulationsyndrome
AT serranuriapons immunoglobulintreatmentinsevereovarianhyperstimulationsyndrome
AT llobellmireiacairo immunoglobulintreatmentinsevereovarianhyperstimulationsyndrome
AT menapedroalmagro immunoglobulintreatmentinsevereovarianhyperstimulationsyndrome